Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
Q2 2017
|
ABIO |
|
Phase 2b Results |
Cardiovascular |
Fast Track |
|
Q2 2017
|
ALNY |
|
Phase 3 Results |
Neurology |
Fast Track, Orphan Drug |
|
H1 2017
|
ARGS |
|
Phase 3 Results |
Oncology |
Fast Track |
|
H1 2017
|
CERC |
|
Phase 2 Results |
Other |
Fast Track |
|
H1 2017
|
CERU |
|
Phase 1/2 Results |
Oncology |
Fast Track, Orphan Drug |
|
H1 2017
|
CLVS |
|
Phase 3 Results |
Oncology |
Breakthrough Therapy |
|
H1 2017
|
CYTX |
|
Phase 3 Results |
Autoimmune |
Orphan Drug |
|
H1 2017
|
FBIO |
|
Phase 2 Results |
Other |
None |
|
H1 2017
|
FGEN |
|
Phase 2 Results |
Respiratory |
Orphan Drug |
|
Not General
|
FLML |
|
Phase 3 Results |
Neurology |
None |
|